Adial Pharmaceuticals Inc (NQ: ADIL )
2.295 USD +0.005 (+0.22%) Streaming Delayed Price Updated: 3:45 PM EST, Jan 26, 2022 Add to My Watchlist
All news about Adial Pharmaceuticals Inc
Avalon Globocare Corps (NASDAQ: AVCO) Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients. AVCO could be the next big Biotech
Today 4:28 EST
NASDAQ Company offers Life Saving Medical Advances; AI and Immunotherapy for Cancer and Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
January 20, 2022
Year End Update for this Up and Coming NASDAQ at the forefront of innovations in healthcare Featuring AI and Immunotherapies. Avalon GloboCare Corp. (NASDAQ:AVCO); Is AVCO the Next BFRI?
January 10, 2022
Monday 1/3 Insider Buying Report: ADIL, IDN
January 03, 2022
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their...
From Market News Video
NASDAQ at the forefront of innovations in healthcare. Avalon GloboCare Corp. (NASDAQ:AVCO): AVCO's Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
December 22, 2021
NASDAQ Companies Including: Biofrontera (NASDAQ:BFRI), Avalon GloboCare Corp. (NASDAQ:AVCO), Palantir Technologies (NYSE: PLTR) and Nvidia (NVDA) lead the Charge and Artificial Intelligence (AI) is at
December 16, 2021
NASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO)
December 09, 2021
Adial Pharmaceuticals Inc(NASDAQ: ADIL) hasannounced data in a preclinical modelof pain reduction. Based on the ...
12 Health Care Stocks Moving In Thursday's Intraday Session
October 21, 2021
Gainers Sio Gene Therapies (NASDAQ:SIOX) stock moved upwards by 22.79% to $2.64 during Thursday's regular session. ...
This NASDAQ has Life Saving Advances in Today's Most Critical Bio-Science Fields of Cancer and Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
October 13, 2021
Avalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
October 07, 2021
Image Provided by Pixabay Cytokine storm has made frequent appearances in the news lately as a life-threatening complication in ...
Adial Pharmaceuticals to Present at Microcap Rodeo's Fall Harvest - Best Ideas from the Buy-Side on Tuesday, October 5, 2021
October 05, 2021
Adial Pharmaceuticals Announces Greater Than 50% of Patients Expected to Complete ONWARD™ Phase 3 Trial of AD04 for the Treatment of Alcohol Use Disorder Have Completed the Full 24-Week Treatment Peri
September 30, 2021
Adial Pharmaceuticals Announces Research Collaboration Agreement with the University of Virginia to Advance Next Generation Adenosine Compounds for Wound Healing
September 28, 2021
Collaboration targeting development of new adenosine formulations that can be absorbed transdermally
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 27, 2021
Gainers Syndax Pharmaceuticals (NASDAQ:SNDX) shares moved upwards by 8.94% to $20.48 during Monday's pre-market ...
Adial CEO William Stilley Invited to Participate in Maxim Group’s Virtual Panel Series Conference: “Disruptors in the Mental Health Space”
September 15, 2021
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Adial Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021
Adial Pharmaceuticals Exceeds Enrollment Target in ONWARD™ Phase 3 Trial of AD04 for the Treatment of Patients with Alcohol Use Disorder
August 31, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
August 26, 2021
Gainers MorphoSys (NASDAQ:MOR) stock moved upwards by 15.07% to $16.26 during Thursday's after-market session. The market value of ...
Adial Pharmaceuticals Reaches Full Enrollment Target for ONWARD™ Phase 3 Trial of AD04 for the Treatment of Patients With Alcohol Use Disorder
August 20, 2021
Adial Pharmaceuticals to Host Conference Call Today at 11AM Eastern to Provide Clinical Update and Discuss Positive Business Developments
August 20, 2021
Adial Pharmaceuticals Schedules Conference Call to Provide Clinical Update and Discuss Positive Business Developments
August 12, 2021
Adial Pharmaceuticals Awarded U.S. and International Patents for the Treatment Of Alcohol and Opioid Use Disorders Using AD04
August 10, 2021
Adial Pharmaceuticals Announces Closing of $5 Million Private Placement Priced at a Premium to Market
August 05, 2021
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! Let's start off the last day of trading this week with a look at the biggest pre-market stock movers for Friday!...